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Edited by Peter BrzezinskiAbstract The mycotoxin cyclopiazonic acid (CPA) is a potent
inhibitor of the sarcoplasmic reticulum Ca2+-ATPase. The
compound decreases the aﬃnity of the Ca2+-ATPase for Ca2+
and reduces the maximum speciﬁc activity of the enzyme.
Furthermore, CPA abolishes the cooperativity of Ca2+ transport,
showing a Ca2+/ATP ratio 1 at any extent of Ca2+ saturation.
There is also an eﬀect on the Ca2+-binding mechanism, where the
addition of CPA results in binding of only half-maximal amount
of Ca2+ observed in its absence. The experimental data suggest
that in the presence of CPA, only a single Ca2+ ion binds to the
Ca2+-ATPase.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Sarcoplasmic reticulum (SR) Ca2þ-ATPase is a 110-kDa
membrane protein that consists of 10 transmembrane helices
(M1–M10), three cytoplasmic domains and small luminal
loops. SR Ca2þ-ATPase is a calcium pump transporting two
mol of Ca2þ across the SR membrane by hydrolytic coupling
with one mol of ATP. According to the E1/E2 theory [1], the
enzyme with bound Ca2þ (E1) is autophosphorylated by ATP
to form E1P. This phosphorylation causes the bound Ca
2þ ions
to be occluded at the transport sites and the subsequent con-
formational transition to the E2P form releases Ca
2þ into the
lumen. Finally, dephosphorylation takes place and returns the
enzyme into the unphosphorylated and Ca2þ-unbound E2
form.
Cyclopiazonic acid (CPA), a mycotoxin produced by certain
strains of Penicillium cyclopium and Aspergillus ﬂavus [2], is a
speciﬁc and potent inhibitor of sarco-endoplasmic reticulum
Ca2þ-ATPase [3–5]. The speciﬁcity of CPA for SR Ca2þ-
ATPase and not for other cation ATPases was also established* Fax: +34 91 585 4401.
E-mail address: fazorin@iib.uam.es (F. Martınez-Azorın).
Abbreviations: CPA, cyclopiazonic acid; SR, sarcoplasmic reticulum;
Pi, inorganic phosphate; pCa, negative logarithm of the molar free
Ca2þ concentration
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doi:10.1016/j.febslet.2004.08.064[4]. The aﬃnity of SR Ca2þ-ATPase for CPA is dependent on
the conformational state of the enzyme, being high in the ab-
sence of Ca2þ but low in its presence [5], because CPA binds to
the Ca2þ-ATPase E2 intermediate and block enzyme turnover
[6]. ATP protected the enzyme against inhibition by CPA,
while Ca2þ had only moderate eﬀect on the extent of inhibition
[4]. Thus, CPA decreases enzyme aﬃnity for ATP but do not
compete for the same binding site [6], because the CPA binding
domain is in the S3 stalk segment (cytoplasmic prolongation of
M3) of the Ca2þ-ATPase [7].
The present work shows that binding of CPA to the Ca2þ-
ATPase results in an uncoupling of ATPase activity by
changing the extent of Ca2þ binding, from the usual two Ca2þ
ions per ATPase molecule to one.2. Materials and methods
2.1. Materials
[3H]Glucose and 45CaCl2 were obtained from DuPont NEM. A
stock solution of CPA from Penicillium cyclopium (Sigma) was pre-
pared in ethanol. The volume of ethanol added did not exceed 1% of
the total volume.
2.2. Sample preparation
A microsomal fraction of SR membrane enriched in Ca2þ-ATPase
protein was isolated from rabbit leg white muscle as previously de-
scribed [8]. The protein content was estimated by the method of Lowry
et al. [9] using bovine serum albumin (BSA) as a standard.
2.3. Free Ca2þ concentration
Reaction media with diﬀerent free Ca2þ concentration were prepared
with the aid of a Ca2þ-EGTA buﬀer according to a computer program
[10] that takes into consideration the association constant for the
Ca2þ-EGTA complex [11] and the equilibrium constants for the EGTA
protonation [12].
2.4. ATPase activity
The rate of ATP hydrolysis was measured at room temperature
following the liberation of inorganic phosphate (Pi) [13]. ATPase ac-
tivity was assayed in a reaction mixture containing 0.05 mg of SR/ml,
20 mM Mops (pH 7), 80 mM KCl, 5 mM MgCl2, 5 mM potassium
oxalate, 1 mM EGTA, 0.967 mM CaCl2 (pCa 5) and diﬀerent CPA
concentrations. After 5 min of incubation, the reaction was started by
the addition of 1 mM ATP. The rates of Pi release were calculated
from the initial phase of time course plots. Ca2þ-independent ATPase
activity was assayed in the presence of 2 mM EGTA and no added
Ca2þ. The Ca2þ-dependent ATPase activity was estimated by sub-
tracting the Ca2þ-independent ATPase from the total activity. The
Ca2þ dependence of the ATPase activity was measured in presence of 1
mM EGTA and diﬀerent Ca2þ concentrations to yield the desired free
concentration.blished by Elsevier B.V. All rights reserved.
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The active transport of Ca2þ was measured at room temperature by
the radioactive tracer method. The incubation medium included 0.05
mg of SR/ml, 20 mM Mops (pH 7), 80 mM KCl, 5 mMMgCl2, 5 mM
potassium oxalate, 1 mM EGTA, diﬀerent 45CaCl2 (4000 cpm/nmol),
0 or 0.75 lM CPA and 1 mM ATP. The Ca2þ accumulated inside the
vesicles was determined by ﬁltering aliquots of 1 ml (0.05 mg of pro-
tein) on HAWP Millipore ﬁlters (0.45 lm) at serial time intervals. The
ﬁlters were rinsed with 3 ml of medium containing 20 mM Mops (pH
7), 80 mM KCl, 5 mM MgCl2 and 1 mM LaCl3 before counting the
45Ca2þ retained on the ﬁlters. The rates of Ca2þ transport were cal-
culated from the initial phase of time course plots.
2.6. Ca2þ binding
The high aﬃnity Ca2þ binding was measured by the double-labeling
ﬁltration technique [14]. The enzyme (0.3 mg of SR/ml) was incubated
at room temperature in a medium consisting of 20 mM Mops (pH 7),
80 mM KCl, 5 mM MgCl2, 69.4 lM EGTA, 1 mM [3H]Glucose
(1000 cpm/nmol), diﬀerent concentrations of CPA and 100 lM
45CaCl2 (5000 cpm/nmol; pCa 4.5). After equilibration for 5 min,
aliquots of 0.2 ml (0.06 mg of protein) were placed onto ﬁlters (Mil-
lipore HAWP 0.45 lm) previously soaked in unlabeled medium and
subjected to vacuum. Counting of radioactive tracers in the incubation
medium and the ﬁlters allowed to determine the Ca2þ bound by sub-
tracting the non-speciﬁc free Ca2þ trapped in each ﬁlter (3H labeling).
2.7. Measurement of parameters
The curves were ﬁtted to the Hill equation expressed as a function of
the K0:5:
Y ¼ N  Cah=ðKh0:5 þ CahÞ
Y being the experimental values, N the maximum Ca2þ-ATPase or
Ca2þ transport activities, K0:5 the Ca2þ concentration needed for half-
activity or apparent aﬃnity constant and h the Hill coeﬃcient.
2.8. Data presentation
The experimental values represent the average of at least three in-
dependent experiments. The standard deviations of the mean values
are given when indicated.3. Results
3.1. Ca2þ-ATPase inhibition
CPA dependence of Ca2þ-ATPase activity. The eﬀect of CPA
was initially assessed by measuring the hydrolytic capacity ofFig. 1. Inhibition of the steady-state ATPase activity of Ca2þ-ATPase
by CPA. The Ca2þ-ATPase activity as a function of CPA concentra-
tions at pCa 5.the Ca2þ-transporting ATPase. Thus, SR vesicles in the pres-
ence of 5 mM potassium oxalate and increasing concentrations
of CPA were preincubated under optimal conditions to mea-
sure the Ca2þ-dependent ATPase activity. As depicted in
Fig. 1, the inhibitory eﬀect elicited by CPA was dependent on
the concentration used as has been shown previously [3–
5,7,15]. These data provide half-inhibition value of approxi-
mately 0.2 lM. Thus, assuming from the maximal EP level
that 1 mg of SR protein contains 4 nmol of Ca2þ-ATPase
active sites (data not shown) [16], it can be deduced a
drug:enzyme molar ratio 1:1 at 0.2 lM.
Ca2þ-dependence of hydrolytic and transport activities. Stea-
dy-state experiments on ATP hydrolysis and Ca2þ transport
were suitable to provide information on the coupling phe-
nomenon.Fig. 2. Steady-state experiment of Ca2þ transport and ATP hydrolysis.
(A) Ca2þ dependence on the Ca2þ-ATPase activity (d, j) or Ca2þ
transport (s, ) of Ca2þ-ATPase measured in the absence (circles) or
presence of 0.75 lM (squares) CPA. (B) Plot of Ca2þ transport versus
Pi release measured at diﬀerent pCa to calculate the coupling factor at
0 (s) or 0.75 lM () CPA.
Table 1
Parameters and coupling values describing the Ca2þ-ATPase activity and Ca2þ-uptake in the presence and in the absence of 0.75 lM CPA
Pi release (d, j) Ca2þ uptake (s, ) Ca2þ/Pi coupling
K0:5 (lM) N (nmol/mg min) h K0:5 (lM) N (nmol/mg min) h
Control 0.39 0.93 1.9 0.41 1.63 1.8 1.9
0.75 lM CPA 0.74 0.57 1.1 0.86 0.65 1.1 1.1
The data from Fig. 2 were ﬁtted to Hill equation.
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the enzyme for Ca2þ from 0.39 lM in the absence of CPA to
0.74 lM at 0.75 lM CPA (Fig. 2A); therefore, higher Ca2þ
concentration are needed to express the same enzymatic ac-
tivity. In addition, lower maximum ATPase activities were
observed at higher CPA concentrations. Thus, the maximum
speciﬁc activity of Ca2þ-ATPase (N ) was 0.93 lmol/mg min
and it was reduced to 0.57 lmol/mg min in presence of 0.75
lM CPA. Meanwhile, the Hill coeﬃcients (h) decreased from
1.9 to 1.1 (Table 1).
The eﬀect of CPA on the Ca2þ-transporting activity is also
shown in Fig. 2A. In the absence of CPA, the data could be
ﬁtted assuming a K0:5, N and h values of 0.41 lM, 1.63 lmol/
mg min and 1.8, respectively, and in presence of 0.75 lMCPA,
0.86 lM, 0.65 lmol/mg min and 1.1, respectively (Table 1).
Therefore, under steady-state conditions, the ATPase inhibi-
tion by CPA is not reversed by addition of higher Ca2þ con-
centration (Fig. 2A).
The stoichiometric ratio between Ca2þ transport and Pi re-
lease in the presence of diﬀerent free Ca2þ concentrations can
be obtained from Fig. 2B. These experiments are suitable to
provide information on the coupling phenomenon because the
passive permeability of the vesicles to Ca2þ after the CPA
treatment is not increased (data not shown) [17]. The coupling
between both processes is given by the slope of the straightFig. 3. Eﬀect of CPA on Ca2þ binding by Ca2þ-ATPase. Binding
of 45Ca2þ to Ca2þ-ATPase as a function of CPA concentration at
pCa 4.5.lines, which is 1.9 in control and 1.1 in the presence of
CPA. These data clearly show that in control, the Ca2þ:ATP
coupling remains unaltered (2) and in presence of CPA it is
reduced (1) within the Ca2þ concentration range used to
saturate the binding sites (Table 1).3.2. Ca2þ binding
In a diﬀerent set of experiments, the binding of Ca2þ to the
Ca2þ-ATPase protein under equilibrium conditions was in-
vestigated. The incubation medium, with a free Ca2þ concen-
tration of 32 lM (pCa 4.5), was supplemented with 1 mM
[3H]glucose in order to evaluate the Ca2þ actually bound to the
protein after the ﬁltration. Thereby, Fig. 3 shows the eﬀect of
CPA on the level of 45Ca2þ bound to the Ca2þ-ATPase. Ad-
dition of CPA at a toxin/enzyme molar ratio 6 1 to the enzyme
reduced the maximal Ca2þ binding (7.5 nmol/mg of protein)
to the half (3.2 nmol/mg of protein). When CPA above an
equimolar level was added, the eﬀect was less sharp. Thus, the
Ca2þ binding capacity tended to decrease and the inhibition
was almost complete when the concentration of CPA was in-
creased up to 300 lM.4. Discussion
In the present work, the eﬀect of CPA on Ca2þ-binding to
the SR Ca2þ-ATPase has been investigated, because most of
Ca2þ-ATPase inhibitors act or aﬀect the Ca2þ-binding mech-
anism [16,18]. CPA concentration dependently inhibits the
activity of the SR Ca2þ-ATPase (Fig. 1), as has been shown
before [3–5,7,15], and the calculated K0:5 (0.2 lM) and molar
ratio (1) are in agreement with those previously published
results [5,7,15].
The most important result presented in this study is the
demonstration that CPA acts reducing the stoichiometric ratio
between Ca2þ transport and Pi release of the Ca2þ-ATPase of
SR, that is, CPA uncouples ATPase activity. In vesicles de-
rived from rabbit white muscle, the hydrolysis of one ATP
molecule leads to the translocation of two Ca2þ ions across the
membrane. This was determined by measuring the ratio be-
tween the initial rates of Ca2þ uptake and ATP hydrolysis
(Fig. 2). In the presence of CPA, the uncoupled hydrolysis of
Ca2þ-ATPase promotes a decrease on the Ca2þ/ATP ratio to
values 1. The data of Fig. 2 and Table 1 show that CPA
reduces the Ca2þ/ATP ratio at all Ca2þ concentrations tested.
This conclusion is also supported by the Ca2þ-binding exper-
iments (Fig. 3). Thereby, the stoichiometry of the high aﬃnity
binding sites was determined and was found to be 7.5 nmol/
mg of protein in the absence of CPA (control), which corre-
sponds to two Ca2þ sites per ATPase monomer, when com-
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[16]). In the presence of CPA at molar ratio 1, the data were
3.4 nmol/mg of protein, which corresponds to one Ca2þ site
per ATPase monomer. In agreement with these data, the Hill
coeﬃcient indicates positive cooperativity in the absence of
CPA (with two Ca2þ binding sites) and non-cooperativity in
the presence of CPA (with only one site). Therefore, it seems
clear that one Ca2þ-binding site is destroyed. However, this
ﬁnding was not obtained clearly in a previous work where the
Ca2þ binding to the Ca2þ-ATPase was also measured after
incubation with CPA (see Fig. 1 in [5]), although the experi-
ments were carried out under diﬀerent conditions.
Previous observations have suggested that CPA interferes
with Ca2þ binding and with the Ca2þ-induced changes in the
conformation of Ca2þ-ATPase [4,17,19].
The mechanism of action of CPA is quite similar to
thapsigargin (TG), the most speciﬁc, potent and the best
characterized inhibitor of SR Ca2þ-ATPase [20]. It has been
shown that binding of TG to the Ca2þ-ATPase also results in a
change in extent of Ca2þ binding, from the usual two Ca2þ
ions per ATPase molecule to one [21].
The two Ca2þ binding sites (I and II) are surrounded by
helices M4, M5, M6 and M8 [22], and the N-terminal region of
M3 helix plays an important role in controlling the Ca2þ entry
pathway [23]. The CPA-binding domain resides at the mem-
brane interface and interacts with S3 stalk segment (cytoplas-
mic prolongation of M3) of the Ca2þ-ATPase [7], which can
explain the eﬀect on the Ca2þ-binding sites. Thereby, changes
in the packing of the transmembrane a-helices result in changes
at the Ca2þ-binding site [24] and large-scale rearrangements of
transmembrane helices take place during Ca2þ-bound and
Ca2þ-free structures transition. As a result, the number of
oxygen atoms that can coordinate to Ca2þ decreases [22] and
site I appears to be more intact in the Ca2þ-free form than site
II. It was suggested that in the process of Ca2þ-binding, Ca2þ
ions pass through site II to reach site I, and that this would
only be possible if site II were not properly formed in the
absence of Ca2þ at site I. Comparison of the Ca2þ-free and
Ca2þ-bound structures suggests that a single binding site for
Ca2þ could exist in the Ca2þ-free structure [25]. The Ca2þ-free
structure is the equivalent to E2 conformation to which the
CPA is bound [6]. Therefore, CPA may act stabilizing this
conformational state of the Ca2þ-ATPase that can bind only
one Ca2þ, thus altering the binding aﬃnity and accessibility of
the site to Ca2þ, or could block the access of Ca2þ to one of the
binding sites. However, this is only a speculative model and
other possibilities remain open.The eﬀect of CPA on Ca2þ-binding of SR Ca2þ-ATPase
described here is additional to the mechanism involved in the
inhibition that has been deeply described before [5,6].
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